The Mutagenicity of Benzidine, 4,4″-Diaminoterphenyl, N,N-Dimethyl-4-aminoazobenzene and 4-Cyano-N,N-dimethylaniline in the L51787 Mouse Lymphoma Assay

  • James C. Kennelly
  • R. Colin Garner


Four compounds were tested for their ability to cause mutation of L5178Y mouse lymphoma cells to 6-thioguanine resistance, as part of the Second UKEMS Collaborative Study. In these preliminary studies, the carcinogen benzidine was observed to have mutagenic activity in this assay in the presence but not the absence of liver S9. The benzidine analogue diaminoterphenyl was inactive. Dimethylaminoazo-benzene was also inactive, but this may have resulted from the use of an inappropriate metabolising system. Cyanodimethylaniline, a compound structurally related to dimethylaminoazobenzene, gave an equivocal result in the presence of S9, in the absence of S9 activation no activity was observed.


Mutation Rate Mutagenic Activity Mutation Assay L5178Y Cell Electronic Cell Counter 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Ashby, J., Styles, J. and Callander, R.D. (1981). Comparative activity of 4,4′-diaminobiphenyl (benzidine) and its terphenyl analogue 4,4″-diaminoterphenyl in two in vitro assays for carcinogenicity. Carcinogenesis 1: 801–802CrossRefGoogle Scholar
  2. Booth, S.C., Welch, A.M. and Garner, R.C. (1980). Some factors influencing mutant numbers in the Salmonella/microsome assay. Carcinogenesis 1: 911–923PubMedCrossRefGoogle Scholar
  3. Campbell, J. and Garner, R.C. (1984). Activity of four UKEMS trial compounds in a HeLa cell DNA repair assay, (this volume) Resolution: GlobalGoogle Scholar
  4. Case, R.A.M., Hosker, M.E., McDonald, D.B. and Pearson, J.T. (1954). Tumours of the urinary bladder in workmen engaged in the manufacture of and use of certain dyestuff intermediates in the British Chemical Industry. Part I, the role of aniline, benzidine, alpha naphthylamine and beta naphthylamine. Br.J. Ind. Med. 67: 75–104Google Scholar
  5. Clive, D., McCuen, R., Spector, J.F.S., Piper, C. and Mavourin, K.H. (1983). Specific gene mutations in L5178Y cells in culture. Mutation Res. 115: 225–251PubMedCrossRefGoogle Scholar
  6. Cole J. and Arlett, C.F. (1976). Ethyl methanesulphanate mutagenesis with L5178Y mouse lymphoma cells; a comparison of ouabain, thioguanine and excess thymidine resistance. Mutation Res. 34: 507–526PubMedCrossRefGoogle Scholar
  7. Cole, J., Fox, M., Garner, R.C, McGregor, D. and Thacker, J. (1983). Gene mutation assays in cultured mammalian cells. In Report of the UKEMS Sub Committee on Guidelines for Mutagenicity Testing (ed. B. Dean). UKEMS Swansea Resolution: GlobalGoogle Scholar
  8. Furth, E.E., Thilly, W.G., Penman, B.W., Liber, H.L. and Rand, W.M. (1981). Quantitative assay for mutation in diploid lymphoblasts using microtitre plates. Anal. Biochem. 110: 1–8PubMedCrossRefGoogle Scholar
  9. Garner, R.C., Walpole, A.L. and Rose, F.L. (1975). Testing of some benzidine analogues for microsomal activation to bacterial mutagens. Cancer Lett. 1: 39–42PubMedCrossRefGoogle Scholar
  10. IPCS (1984). Recommendations of IPCS International Short-term Trial. Elsevier/ North Holland. In press.Google Scholar
  11. Martin, C.N., McDermid, A.C. and Garner, R.C. (1978). Testing of known carcinogens and noncarcinogens for their ability to induce unscheduled DNA synthesis in Hela cells. Cancer Res. 38: 2621–2627PubMedGoogle Scholar
  12. Miller, J.A. and Miller E.C. (1953). The carcinogenic aminoazo dyes. Adv. Cancer Res. 1: 339–396PubMedCrossRefGoogle Scholar

Copyright information

© United Kingdom Environmental Mutagen Society 1985

Authors and Affiliations

  • James C. Kennelly
    • 1
  • R. Colin Garner
    • 2
  1. 1.Microtest Research LtdUniversity RoadUK
  2. 2.Cancer Research UnitUniversity of YorkHeslingtonUK

Personalised recommendations